MICROPORT® MEDBOT™ TOUMAI™ ENDOSCOPIC SURGICAL ROBOT SYSTEM PERFORMS MULTIPLE ROBOTIC TELESURGERIES IN THE REPUBLIC OF ANGOLA

Thursday, October 31, 2024

On October 24, 2024, MicroPort ®  MedBot TM (HKSE:2252) announced that the company has successfully performed six robotic-assisted laparoscopic radical prostatectomy procedures in the Republic of Angola . The surgeries were performed by Dr. Vipul Patel , a world-renowned robotic urological surgeon for his contributions to the field of robotic-assisted surgery and one of the most experienced robotic surgeons in the world, having personally performed over 18,000 robotic prostatectomies, and his surgical team based at AdVent Health's Global Robotics Institute in Celebration, Florida, United States of America. The urology operations were performed at the Complexo Hospitalar de Doenças Cardio-Pulmonar Cardeal Dom Alexandre do Nascimento (Cardeal) which is located in the city of Luanda and was established as the National Health Reference Center for Angola .

Of these six successful surgical cases and for the first time in the sub-Saharan Africa region, two were performed remotely using the Toumai TM telesurgery capability . Robotic telesurgery is a surgical procedure in which a surgeon performs an operation on a patient remotely using a robot and a telecommunications network. For these telesurgery cases, the main robotic console and the remote console were located at separate sites on the Cardeal hospital campus, with the connection between the main and remote consoles using only the Toumai TM telesurgery console  and Cardeal’s internal telecommunications network. The total latency between the main and remote systems for these robotic surgery cases was less than six milliseconds.

“My team came to Angola to help the country with a humanitarian goal. The potential of robotics, telesurgery and education is the future of healthcare equity for countries like Angola , ” says Dr. Vipul Patel . “By being able to operate remotely, we have demonstrated for the first time in Africa the potential path to future humanitarian success. Today, the entire team has proven the concept, but we must exercise caution and safety going forward.”

One of the key features of the Toumai TM system  is its telesurgery application, which holds transformative potential for the future of healthcare. Telesurgery allows surgeons to perform procedures remotely, leveraging high-speed data transfer and real-time communication. This capability is particularly crucial for extending specialized surgical care to underserved or remote areas, thereby bridging gaps in healthcare access. By enabling expert surgeons to guide complex operations remotely, telesurgery not only improves the reach of medical services, but also ensures that patients in remote locations receive the highest standards of care. This innovative approach can significantly reduce disparities in healthcare access and improve outcomes across diverse populations. To date, Toumai TM  has successfully performed over 200 cases of human robotic telesurgery worldwide.

“We are proud to be a part of these historic cases of robotic telesurgery to bring the Toumai TM system  to this region of the world,” said Dr. He Chao, Founder and Chairman of MicroPort ®  MedBot TM . “In time, we will look back on this date and recognize it as the founding event of the healthcare revolution in Angola with Toumai TM  and the promise of telesurgery.”

 The MicroPort ®  Medbot TM Toumai TM Surgical Robot System  is specifically designed to improve outcomes and operational efficiency in all surgical procedures. Designed with surgeons and patients in mind, the Toumai TM system  integrates advanced robotics, high-definition 3D visualization, and intuitive control interfaces to provide surgeons with an unprecedented level of precision and control. Toumai TM  is currently approved for urology, thoracic, general, gynecologic, thyroid, breast, and pediatric surgeries. Toumai TM  is currently approved and commercially available in China, the European Union, and other countries recognizing NMPA approvals and CE marking. 



Source: prnewswire.com